封面
市場調查報告書
商品編碼
1935221

神經系統疾病診斷市場按技術、疾病、最終用戶和地區分類

Neurological Disorder Diagnostics Market, By Technology, By Disease Indication, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,神經系統疾病診斷市場價值將達到 137.6 億美元,到 2033 年將達到 158.7 億美元,2026 年至 2033 年的年複合成長率(CAGR)為 9.1%。

報告覆蓋範圍 報告詳情
基準年: 2025 2026年市場規模: 137.6億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
預測期(2026-2033年)複合年成長率: 9.10% 2033 年的預測值: 158.7億美元

神經系統診斷工具用於診斷各種神經系統疾病,例如阿茲海默症、帕金森氏症和亨廷頓氏症。神經系統疾病的診斷可採用影像學和體外診斷技術。影像學技術,例如電腦斷層掃描(CT)和磁振造影(MRI),可以產生器官、骨骼、軟組織、血管和其他身體部位的詳細影像。另一方面,體外診斷技術包括切片檢查、生物標記檢測、血液檢測、尿液檢查和基因檢測。

市場動態

神經系統疾病診斷設備的科技創新和發展預計將推動市場成長。例如,2017年,東軟醫療系統公司研發出創新型CT掃描儀“NeuViz Prime CT掃描儀”,並獲得了美國食品藥物管理局(FDA)的核准。此外,2016年,皇家飛利浦公司在加拿大推出了「IQon Spectral CT」。 IQon Spectral CT是頻譜專為頻譜成像設計的光譜檢測器CT。

本次調查的主要特點

  • 本報告對全球神經系統疾病診斷市場進行了詳細分析,以 2018 年為基準年,給出了預測期(2019-2027 年)的市場規模和復合年成長率(%)。
  • 該報告還重點介紹了各個細分市場的潛在商機,並概述了該市場具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
  • 本報告根據以下參數對全球神經診斷市場的主要企業進行了分析:公司概況、財務績效、產品系列、市場地位、分銷策略、主要發展、策略和未來計劃。
  • 本報告的研究結果將使企業負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球神經系統疾病診斷市場報告的目標受群眾外包括該行業的各類相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過全球神經診斷市場分析中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、監理及趨勢分析

  • 市場動態
    • 促進要素
    • 抑制因素
    • PEST分析
    • 波特五力分析
    • 市場機遇
    • 法規環境
    • 重大進展
    • 產業趨勢

4. 2026-2033年全球神經診斷市場(依技術分類)

  • 影像診斷
  • 體外診斷

5. 2026-2033年全球神經學診斷市場(依疾病分類)

  • 遺傳性神經系統疾病
  • 免疫介導的神經系統疾病
  • 副腫瘤症候群
  • 副蛋白血症神經病變
  • 其他

6. 2026-2033年全球神經系統疾病診斷市場(依最終用戶分類)

  • 醫院和診所
  • 診斷中心
  • 門診治療中心

7. 2026-2033年全球神經學診斷市場(按地區分類)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • 熱圖分析
  • 市佔率分析(3x3矩陣)
  • 公司簡介
    • Siemens Healthineers
    • Koninklijke Philips NV
    • General Electric Company
    • Esaote SpA
    • NeuroLogica Corporation
    • Masimo Corporation
    • York Instruments Ltd.
    • Neusoft Medical Systems
    • Canon Medical Systems Corporation

第9章 分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第10章各節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1867

Neurological Disorder Diagnostics Market is estimated to be valued at USD 13.76 Bn in 2026 and is expected to reach USD 15.87 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 13.76 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.10% 2033 Value Projection: USD 15.87 Bn

Neurological disorder diagnostic tools are used for the diagnosis of various neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease and others. Neurological disorders can be diagnosed with the use of imaging and in vitro diagnostic techniques. Imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) are used to create detailed images of organs, bones, soft tissue, blood vessels, and other parts of body. Whereas, in-vitro diagnostic techniques include biopsy, biomarker, blood test, urine test, and genetic testing.

Market Dynamics

Technological innovations and developments in neurological disorder diagnosing devices are expected to drive the market growth. For instance, in 2017, Neusoft Medical Systems developed an innovative CT scanner NeuViz Prime CT Scanner and received the U.S. Food and Drug Administration approval for the system. Moreover in 2016, Koninklijke Philips N.V. launched IQon Spectral CT in Canada. IQon Spectral CT is a spectral detector CT, designed specifically for spectral imaging.

Key features of the study

  • This report provides in-depth analysis of the global neurological disorder diagnostics market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global neurological disorder diagnostics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology upgradation, market expansion, and marketing tactics
  • The global neurological disorder diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurological disorder diagnostics market

Market Segmentation

  • By Technology
    • Imaging
    • In Vitro Diagnostics
  • By Disease Indication
    • Genetic Neurological Disorders
    • Immunological Neurological Disorders
    • Paraneoplastic Syndrome
    • Paraproteinemic Neuropathies
    • Others
  • By End User
    • Hospitals & Clinics
    • Diagnostic Centers
    • Ambulatory Care Centers
  • By Regional Insights
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Siemens Healthineers
    • Koninklijke Philips N.V.
    • General Electric Company
    • Esaote SpA
    • NeuroLogica Corporation
    • Masimo Corporation
    • York Instruments Ltd.
    • Neusoft Medical Systems
    • Canon Medical Systems Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Disease Indication
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • PEST Analysis
    • PORTER's Five Forces Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trend

4. Global Neurological Disorder Diagnostics Market, By Technology, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Imaging
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • In Vitro Diagnostics
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

5. Global Neurological Disorder Diagnostics Market, By Disease Indication, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Genetic Neurological Disorders
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Immunological Neurological Disorders
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Paraneoplastic Syndrome
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Paraproteinemic Neuropathies
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

6. Global Neurological Disorder Diagnostics Market, By End User, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals & Clinics
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diagnostics Centers
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Ambulatory Care Centers
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

7. Global Neurological Disorder Diagnostics Market, By Region, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • North America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Siemens Healthineers
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Koninklijke Philips N.V.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • General Electric Company
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Esaote SpA
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • NeuroLogica Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Masimo Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • York Instruments Ltd.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Neusoft Medical Systems
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Canon Medical Systems Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates

9. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact